Illumina Ventures
Venture capitalFoster City · Pre-Seed–Late Stage · 40 people tracked
Also known as IIF MANAGEMENT COMPANY, LLC
Investment thesis
Illumina Ventures positions itself as a leader in genomics and precision health investing. The firm concentrates on building the broader ecosystem around these fields and translating capital into innovation, with the stated goal of accelerating positive impact on human health.
Source: firm website, verified Aug 3, 2026.
Team · 40 people
from the firm's website & public directories
What they invest in
from 40 of 51 portfolio companiesBiotech ×35Deep Tech ×15Medical Devices ×15AI & Machine Learning ×13Digital Health ×11Healthtech ×8AgTech ×2Climate Tech ×1
HQs:United States×15Sweden×1
Investments · 51 tracked
founders shown can be your intro pathCastle Biosciences develops genomic tests that provide personalized biological information to inform disease diagnosis, treatment selection, and follow-up care decisions for healthcare providers and patients.
BiotechDigital HealthMedical Devices
Precede Biosciences develops a blood-based diagnostic platform that profiles gene expression from cell-free DNA to reveal disease biology at the transcriptional level for drug developers and clinical trials.
AI & Machine LearningBiotechDigital HealthBoston, US
Rehan Verjee(Co-Founder, Chief Executive Officer, Board Director)Sylvan Baca(Co-Founder; Assistant Professor of Medicine, Dana-Farber Cancer Institute)Toni Choueiri(Co-Founder; Director, Lank Center for GU Oncology, Dana-Farber Cancer Institute)Matthew Freedman(Co-Founder; Professor of Medicine, Dana-Farber Cancer Institute)
Actym develops engineered bacterial therapeutics for cancer and fibrotic disease treatment, using a proprietary STACT™ platform based on Salmonella typhimurium as a delivery vehicle for localized therapeutic payloads.
BiotechDigital HealthMedical Devices
Adventris is a biotechnology company developing cancer immunotherapy treatments.
BiotechHealthtechBaltimore, US
Jen Herbach(Founder)inWilliam Collis(Founder)inMark Yarchoan(Founder)
Arbor develops programmable DNA editors for genetic medicine, aiming to enable functional cures for patients by addressing genetic diseases through bespoke gene editing approaches.
BiotechDigital HealthMedical DevicesCambridge, US
KEITH CRANDELL(Director)DAVID ARTHUR SCOTT(Executive Officer)WINSTON XIA YAN(Executive Officer)ANNIE HAZLEHURST(Director)FENG ZHANG(Director)
BoardDAVID R. WALT(Director)
Arima Genomics develops DNA-based cancer diagnostics that combine genomic sequence with structural information to detect cancer-driving mutations and rearrangements.
BiotechDigital HealthMedical Devices
Attovia develops precision biologics using its ATTOBODY platform for patients with immune-mediated diseases.
BiotechDigital Health
Broken String Bio develops genome-wide on- and off-target analysis software and sequencing technology for gene editing research and development.
BiotechDeep TechMedical Devices
Bullseye Biosciences discovers drug molecules directly in living cells using directed evolution to target difficult intracellular proteins and protein interactions implicated in cancer and other serious diseases.
AI & Machine LearningBiotechDeep Tech
BiotechPittsburgh, US
Noel Doheny(Director)Michael Hoerres(Executive Officer, Director)James Peters(Director)Steve Grenfell(Director)Paul Schmitt(Director)
CubaseBio develops spatial biology tools that enable three-dimensional analysis of biological samples at scale, for drug discovery and biological research.
BiotechDeep TechStockholm, SE
DeepSeq uses AI to design biologics by analyzing vast numbers of protein interactions to predict affinity, specificity, immunogenicity, pharmacokinetics, and manufacturability.
AI & Machine LearningBiotechDeep Tech
DELFI Diagnostics develops FirstLook Lung, a blood-based laboratory test for lung cancer screening that identifies genome-wide alterations in individuals eligible for screening.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesBaltimore, US
Peter Bach(Executive Officer)Elizabeth Homans(Director)Rishi Gupta(Director)Justin Kao(Director)Jennifer Buechel(Executive Officer)Victor Velculescu(Executive Officer, Director, Promoter)
Encoded develops gene therapies for neurological disorders through an integrated platform approach.
Biotech
Fluent Bio develops software for analyzing single-cell RNA sequencing data, producing count matrices and diagnostic outputs for researchers using Illumina sequencing libraries.
BiotechDeveloper Tools
Fuze Health provides technology-led healthcare services including disease screening, genomics, telehealth, digital pharmacy, and patient engagement to help partners deliver personalized care.
AI & Machine LearningDigital HealthHealthtech
Infinity Bio develops molecular indexing technology to decode antibody-antigen binding interactions for research and therapeutic applications in the biotech field.
Biotech
Integrated Biosciences develops a platform for small molecule drug discovery targeting age-related diseases by combining optogenetics, chemistry, and AI to probe disease biology with precision and explore chemical space systematically.
AI & Machine LearningBiotechLongevityRedwood City, US
Felix Wong(Executive Officer, Director)Keith Loebner(Director)Themasap Khan(Director)
Kodikaz develops Zip-Code, a non-viral cell-specific delivery platform for gene therapy applications, particularly focused on oncology and cancer treatments.
AI & Machine LearningBiotechMedical DevicesAtlanta, US
Anthony Johnson(Co-Founder & CEO)inDr. Leon Bernal-Mizrachi(Co-Founder, CSO)in
Lightcast provides a next-generation single-cell functional analysis platform called Envisia that enables massively parallel profiling of cell-cell interactions and biomolecule secretion at scale.
BiotechDeep TechMedical Devices
NanoCellect manufactures microfluidic cell sorting systems for laboratory and research applications.
BiotechMedical Devices
NuCicer develops improved crop varieties through selective breeding, starting with high-protein chickpeas designed for better nutrition.
AgTechAI & Machine LearningFoodTechDavis, US
Paimun Amini(Director)inKathryn Cook(Executive Officer, Director)inDouglas Cook(Executive Officer, Director)
Pluton develops a soil-surface biological nutrient system powered by photosynthetic microbes that delivers nitrogen and improves phosphorus availability for crops while reducing nutrient loss.
AgTechBiotechClimate TechDeep Tech
Charlie Walch(Executive Officer, Director)Barry Goldman(Executive Officer, Director)Glendon Schuster(Director)
Predicta develops a molecular insights platform for blood cancer care that generates genomic and immune profiling from blood samples to guide treatment decisions and monitor disease evolution.
BiotechDigital HealthMedical DevicesCambridge, US
Protillion Biosciences develops platform technology for antibody engineering and drug discovery.
AI & Machine LearningBiotechDeep TechCarlsbad, US
Curtis Layton(CEO/Co-Founder)inDavid Walt(Co-Founder)inWill Greenleaf(Co-Founder)inRobert Hollingsworth(Chief Scientific Officer)inSean Kendall(Director)Malek Faham(Director)
Santa Clara, US
Ronald M. Cook(Director)Tom Willis(Director, Executive Officer)Jekwan Ryu(Executive Officer, Director)Eric Williams(Executive Officer)Tae Hoon Nahm(Director)
Redshift Bio develops real-time monitoring technology for biomolecular structure and concentration analysis in biopharmaceutical development and manufacturing.
BiotechDeep TechEnterprise Software
Frank Smith(Director)William Cadogan(Director)Bryson Hollimon(Director)Susan Holleran(Director)Wouter Meuleman(Director)Thomas O'Lenic(Executive Officer, Director)
BiotechGreenville, US
Katherine Warner(Executive Officer)Mike Dial(Director)Joshua Resnick(Director)Michael Solomon(Director)Kevin Weeks(Executive Officer, Director)John Gustofson(Director)
Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.
BiotechHealthtechNew York City, US
HealthtechCambridge, US
Rahul Dhanda(Executive Officer, Director)James Collins(Director)Issi Rozen(Director)David Walt(Director)
Medical Devices
Frequently asked questions
- What stage does Illumina Ventures invest at?
- Illumina Ventures invests at the Pre-Seed, Seed, Series A, Late Stage stages.
- What sectors does Illumina Ventures focus on?
- Illumina Ventures focuses on Biotech, Digital Health, Healthtech, Longevity, Medical Devices.
- Where is Illumina Ventures located?
- Illumina Ventures is headquartered in Foster City, US.
- Does Illumina Ventures lead rounds?
- Illumina Ventures typically participates in rounds rather than leading them.
Co-investors · 11
5AM Ventures is a life science venture capital firm founded in 2002 that invests primarily in private therapeutic companies, with a focus on biopharmaceuticals, drug delivery technologies, and life science instruments.
Kurma Partners is a European healthcare-focused investment firm that co-founds and finances biotech and healthcare companies, working closely with research centers to translate scientific discoveries into high-tech companies.
Qiming Venture Partners is a China-focused venture capital firm that backs entrepreneurs across technology and healthcare sectors, taking active board and strategic roles from early rounds through public listings.
+ND Capital is an investment firm founded in 2002, focused on nanotechnology and deep science companies, investing in opportunities across Europe and the US.
Transformation Capital is an investment firm focused exclusively on the healthcare industry, backing companies transforming healthcare delivery and services.
Paladin Capital Group is a global investment firm backing innovative companies in cybersecurity, secure AI, and deep tech.
EQT Life Sciences, formerly LSP, is one of Europe's largest and most experienced life sciences investors, backing companies developing therapeutics, medical devices, diagnostics and healthtech globally. It is part of EQT Group.
Sofinnova Partners is a life sciences venture capital firm investing across the value chain from seed to later stage, with a focus on healthcare and sustainability. It backs companies in biopharma, medtech, digital medicine, agriculture and industrial processes.
Genoa Ventures is a venture capital firm that works with strategic partners providing market insights, validated deal flow, and domain expertise to support its portfolio companies.
Catalio is a software platform that uses AI to automatically extract and document business logic from legacy and modern systems, creating living specifications that stay current as software evolves.
Casdin Capital is an investment firm focused on the life sciences, investing across healthcare, biotechnology, synthetic biology, and related technology.
Firms observed investing alongside Illumina Ventures, from public investor directories. Shared companies are the overlap with Illumina Ventures's recorded portfolio.
Similar investors
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
Lumira Ventures is a North American life sciences venture capital firm that partners with mission-driven entrepreneurs to build companies developing and commercializing healthcare products for patients.
OrbiMed is a global healthcare-focused investment firm providing financing and operational support to companies across biopharmaceuticals, medical devices, digital health, diagnostics, and healthcare services.
Foresite Capital is a multi-stage investment firm focused on healthcare and life sciences, backing companies across all stages of growth. It applies a data science-driven approach to invest in businesses leveraging biology and big data to transform healthcare.
Pontifax is an investment firm focused on life sciences and healthcare technologies, backing companies across all development stages from early research to clinical-stage growth.